Enhanced skin drug delivery using dissolving microneedles : a potential approach for the management of skin disorders
INTRODUCTION: For decades, finding effective long-term or disease-modifying treatments for skin disorders has been a major focus of scientists. The conventional drug delivery systems showed poor efficacy with high doses and are associated with side effects, which lead to challenges in adherence to therapy. Therefore, to overcome the limitations of conventional drug delivery systems, drug delivery research has focused on topical, transdermal, and intradermal drug delivery systems. Among all, the dissolving microneedles have gained attention with a new range of advantages of drug delivery in skin disorders such as breaching skin barriers with minimal discomfort and its simplicity of application to the skin, which allows patients to administer it themselves.
AREAS COVERED: This review highlighted the insights into dissolving microneedles for different skin disorders in detail. Additionally, it also provides evidence for its effective utilization in the treatment of various skin disorders. The clinical trial status and patents for dissolving microneedles for the management of skin disorders are also covered.
EXPERT OPINION: The current review on dissolving microneedles for skin drug delivery is accentuating the breakthroughs achieved so far in the management of skin disorders. The output of the discussed case studies anticipated that dissolving microneedles can be a novel drug delivery strategy for the long-term treatment of skin disorders.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:20 |
---|---|
Enthalten in: |
Expert opinion on drug delivery - 20(2023), 6 vom: 23. Juni, Seite 721-738 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Priya, Sakshi [VerfasserIn] |
---|
Links: |
---|
Themen: |
Dissolving microneedles |
---|
Anmerkungen: |
Date Completed 23.06.2023 Date Revised 25.06.2023 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1080/17425247.2023.2190095 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM35399152X |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM35399152X | ||
003 | DE-627 | ||
005 | 20231226061245.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1080/17425247.2023.2190095 |2 doi | |
028 | 5 | 2 | |a pubmed24n1179.xml |
035 | |a (DE-627)NLM35399152X | ||
035 | |a (NLM)36893450 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Priya, Sakshi |e verfasserin |4 aut | |
245 | 1 | 0 | |a Enhanced skin drug delivery using dissolving microneedles |b a potential approach for the management of skin disorders |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 23.06.2023 | ||
500 | |a Date Revised 25.06.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a INTRODUCTION: For decades, finding effective long-term or disease-modifying treatments for skin disorders has been a major focus of scientists. The conventional drug delivery systems showed poor efficacy with high doses and are associated with side effects, which lead to challenges in adherence to therapy. Therefore, to overcome the limitations of conventional drug delivery systems, drug delivery research has focused on topical, transdermal, and intradermal drug delivery systems. Among all, the dissolving microneedles have gained attention with a new range of advantages of drug delivery in skin disorders such as breaching skin barriers with minimal discomfort and its simplicity of application to the skin, which allows patients to administer it themselves | ||
520 | |a AREAS COVERED: This review highlighted the insights into dissolving microneedles for different skin disorders in detail. Additionally, it also provides evidence for its effective utilization in the treatment of various skin disorders. The clinical trial status and patents for dissolving microneedles for the management of skin disorders are also covered | ||
520 | |a EXPERT OPINION: The current review on dissolving microneedles for skin drug delivery is accentuating the breakthroughs achieved so far in the management of skin disorders. The output of the discussed case studies anticipated that dissolving microneedles can be a novel drug delivery strategy for the long-term treatment of skin disorders | ||
650 | 4 | |a Review | |
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a Dissolving microneedles | |
650 | 4 | |a drug delivery | |
650 | 4 | |a macromolecules | |
650 | 4 | |a skin disorders | |
650 | 4 | |a transdermal delivery | |
700 | 1 | |a Tomar, Yashika |e verfasserin |4 aut | |
700 | 1 | |a Desai, Vaibhavi Meghraj |e verfasserin |4 aut | |
700 | 1 | |a Singhvi, Gautam |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Expert opinion on drug delivery |d 2004 |g 20(2023), 6 vom: 23. Juni, Seite 721-738 |w (DE-627)NLM159019028 |x 1744-7593 |7 nnns |
773 | 1 | 8 | |g volume:20 |g year:2023 |g number:6 |g day:23 |g month:06 |g pages:721-738 |
856 | 4 | 0 | |u http://dx.doi.org/10.1080/17425247.2023.2190095 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 20 |j 2023 |e 6 |b 23 |c 06 |h 721-738 |